´Sit Less, Move More' at Work: mHealth Intervention on Office Employees With Diabetes Type 2.

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1. 1This trial focuses on sitting less and moving more during the workday — given my current diabetes management routine, do you think a workplace activity intervention like this could realistically help lower my fasting glucose or HbA1c levels?
2. 2Since this study is listed with an unknown recruitment status, do you know whether it's still actively enrolling, and would it even be possible for me to participate at this point?
3. 3The trial targets office employees specifically — since it's built around a workplace setting, would my particular job situation or work schedule make it difficult to follow the program as designed?
4. 4This study is measuring changes in weight, BMI, and waist circumference alongside blood sugar markers — based on where I am right now with those numbers, do you think a movement-based intervention is the right priority, or should we focus on other parts of my diabetes treatment first?
5. 5Since this trial has no listed phase and appears to be a behavioral intervention rather than a drug study, what does that mean for how much we already know about its safety and effectiveness compared to more established diabetes management options?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.